U.S. Central Venous Catheter Market is expected to be valued at US$ 1,657.13 million at a CAGR of 6.2% in 2030 | AngioDynamics, Inc, C.R. Bard, Inc, Teleflex Incorporated, B. Braun Melsungen AG

Overview:

Central venous catheters have become important part of modern healthcare, as they make administering intravenous fluids, medications, parenteral nutrition, and blood products easy. Moreover, this product also offers hemodynamic monitoring and hemodialysis access. The use of these catheters for long term is common in diseases such as end stage renal disease (dialysis) and cancer (chemotherapy).

Click Here to Get a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/2610

Market Drivers:

Growing number of cancer and renal disease requiring long-term treatments such as chemotherapy and dialysis is expected to propel growth of the U.S. central venous catheter market over the forecast period. For instance, as per the National Center for Chronic Disease Prevention and Health Promotion, 2017, chronic disease was estimated to affect nearly 30 million individual which is 15% of adults in the U.S. Moreover, as per the data of World Health Organization (WHO), cancer affected nearly 14 million individuals in 2012 being the second most cause of mortality and morbidity. According to the same source (WHO), the number of new cancer cases is likely to increase by 70% by the year 2030.

Furthermore, major players in the market are focusing on adoption of inorganic growth strategies such as M&A in order to strengthen their product portfolio, and this in turn is projected to boost growth of the U.S. central venous catheter market over the forecast period. For instance, in 2017, Becton, Dickinson, and Company announced acquisition of C.R. Bard, Inc. that made the company a new leader in healthcare industry with nearly US$ 16 billion yearly revenue.

Ask For Discount Before Purchasing This Business Report : https://www.coherentmarketinsights.com/insight/request-discount/2610

Moreover, in July 2018, B. Braun Melsungen AG completed the acquisition of bloodlines business of NxStage Medical, Inc.

Key Takeaways:

• The U.S. central venous catheter market is anticipated to show a CAGR of 6.2% during the forecast period due to rise in cancer prevalence.
• The segment of peripherally inserted central catheters (PICC), among Product Type, is likely to witness significant growth in the S. central venous catheter market due to increasing commercial availability of peripherally inserted central catheters.
• The multi lumen segment among Designs is expected to witness strong growth in the U.S. central venous catheter market, owing to lucrative properties of polyurethane such as thinner lumen walls, toughness and bigger internal diameter.
• The chemotherapy procedure segment among Procedures is anticipated to witness robust growth in the U.S. central venous catheter market due to growing number of cancer cases.

Key Players:

Major players active in the U.S. central venous catheter market are Theragenics Corporation, Cobra Biologics and Pharmaceutical Services, ICU Medical, Inc., VGXI, Inc., Argon Medical Devices, Inc., Aldevron, Cook Medical, Inc., Kaneka Corporation, Vygon Ltd., Nature Technology Corporation, Medtronic Plc., PlasmidFactory GmbH & Co. KG, B. Braun Melsungen AG, Cell and Gene Therapy Catapult, Teleflex Incorporated, Waisman Biomanufacturing, C. R. Bard, Inc., and AngioDynamics, Inc.

Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/2610

The Study Objectives are:

✔ A comprehensive insight into key players operating in the U.S. Central Venous Catheter Market and their corresponding data.
✔ It includes product portfolio, annual revenue, expenditure on research and development, geographical presence, key developments in recent years, and growth strategies.
✔ Regional analysis, which includes insight into the dominant market and corresponding market share.
✔ It also includes various socio-economic factors affecting the evolution of the market in the region.
✔ The report offers a comprehensive insight into different individuals from value chains such as raw materials suppliers, distributors, and stockholders.

Table of Content

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 U.S. Central Venous Catheter Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: U.S. Central Venous Catheter Industry Impact

Chapter 2 U.S. Central Venous Catheter Competition by Types, Applications, and Top Regions and Countries
2.1 U.S. Central Venous Catheter (Volume and Value) by Type
2.3 U.S. Central Venous Catheter (Volume and Value) by Regions

Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 U.S. Central Venous Catheter Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 Company Profiles and Key Figures in U.S. Central Venous Catheter Business
Chapter 6 U.S. Central Venous Catheter Market Forecast (2022-2028)
Chapter 7 Conclusions
Research Methodology